DZNep inhibits histone methylation, reduces cellular Ezh2, and alters... | Download Scientific Diagram
![Frontiers | Histone Methylation Inhibitor DZNep Ameliorated the Renal Ischemia-Reperfusion Injury via Inhibiting TIM-1 Mediated T Cell Activation | Medicine Frontiers | Histone Methylation Inhibitor DZNep Ameliorated the Renal Ischemia-Reperfusion Injury via Inhibiting TIM-1 Mediated T Cell Activation | Medicine](https://www.frontiersin.org/files/Articles/529729/fmed-07-00305-HTML/image_m/fmed-07-00305-g003.jpg)
Frontiers | Histone Methylation Inhibitor DZNep Ameliorated the Renal Ischemia-Reperfusion Injury via Inhibiting TIM-1 Mediated T Cell Activation | Medicine
![DZNep, an inhibitor of the histone methyltransferase EZH2, suppresses hepatic fibrosis through regulating miR-199a-5p/SOCS7 pathway [PeerJ] DZNep, an inhibitor of the histone methyltransferase EZH2, suppresses hepatic fibrosis through regulating miR-199a-5p/SOCS7 pathway [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2021/11374/1/fig-2-full.png)
DZNep, an inhibitor of the histone methyltransferase EZH2, suppresses hepatic fibrosis through regulating miR-199a-5p/SOCS7 pathway [PeerJ]
![DZNep, an inhibitor of the histone methyltransferase EZH2, suppresses hepatic fibrosis through regulating miR-199a-5p/SOCS7 pathway [PeerJ] DZNep, an inhibitor of the histone methyltransferase EZH2, suppresses hepatic fibrosis through regulating miR-199a-5p/SOCS7 pathway [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2021/11374/1/fig-1-full.png)
DZNep, an inhibitor of the histone methyltransferase EZH2, suppresses hepatic fibrosis through regulating miR-199a-5p/SOCS7 pathway [PeerJ]
3-Deazaneplanocin A (DZNep), an Inhibitor of the Histone Methyltransferase EZH2, Induces Apoptosis and Reduces Cell Migration in Chondrosarcoma Cells
![Epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A inhibits the growth of cholangiocarcinoma cells Epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A inhibits the growth of cholangiocarcinoma cells](https://www.spandidos-publications.com/article_images/or/31/2/OR-31-02-0983-g01.jpg)
Epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A inhibits the growth of cholangiocarcinoma cells
![3-Deazaneplanocin,DZNep | CAS:102052-95-9 | Cell-permeable histone methyltransferase inhibitor | High Purity | Manufacturer BioCrick 3-Deazaneplanocin,DZNep | CAS:102052-95-9 | Cell-permeable histone methyltransferase inhibitor | High Purity | Manufacturer BioCrick](https://www.biocrick.com/media/images/struct3D/BCC1129.png)
3-Deazaneplanocin,DZNep | CAS:102052-95-9 | Cell-permeable histone methyltransferase inhibitor | High Purity | Manufacturer BioCrick
![Molecular mechanisms involved in the synergistic interaction of DZNeP... | Download Scientific Diagram Molecular mechanisms involved in the synergistic interaction of DZNeP... | Download Scientific Diagram](https://www.researchgate.net/profile/Amir-Avan/publication/225058331/figure/fig2/AS:601788604502028@1520488992425/Molecular-mechanisms-involved-in-the-synergistic-interaction-of-DZNeP-with-gemcitabine.png)
Molecular mechanisms involved in the synergistic interaction of DZNeP... | Download Scientific Diagram
![EZH2-inhibitor DZNep enhances apoptosis of renal tubular epithelial cells in presence and absence of cisplatin | Cell Division | Full Text EZH2-inhibitor DZNep enhances apoptosis of renal tubular epithelial cells in presence and absence of cisplatin | Cell Division | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13008-020-00064-3/MediaObjects/13008_2020_64_Fig5_HTML.png)
EZH2-inhibitor DZNep enhances apoptosis of renal tubular epithelial cells in presence and absence of cisplatin | Cell Division | Full Text
![A Compound AC1Q3QWB Selectively Disrupts HOTAIR-Mediated Recruitment of PRC2 and Enhances Cancer Therapy of DZNep A Compound AC1Q3QWB Selectively Disrupts HOTAIR-Mediated Recruitment of PRC2 and Enhances Cancer Therapy of DZNep](https://www.thno.org/v09/p4608/toc.jpg)
A Compound AC1Q3QWB Selectively Disrupts HOTAIR-Mediated Recruitment of PRC2 and Enhances Cancer Therapy of DZNep
![Acquired resistance to DZNep-mediated apoptosis is associated with copy number gains of AHCY in a B-cell lymphoma model | BMC Cancer | Full Text Acquired resistance to DZNep-mediated apoptosis is associated with copy number gains of AHCY in a B-cell lymphoma model | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-020-06937-8/MediaObjects/12885_2020_6937_Fig1_HTML.png)
Acquired resistance to DZNep-mediated apoptosis is associated with copy number gains of AHCY in a B-cell lymphoma model | BMC Cancer | Full Text
![Histone methylases as novel drug targets: developing inhibitors of EZH2 | Future Medicinal Chemistry Histone methylases as novel drug targets: developing inhibitors of EZH2 | Future Medicinal Chemistry](https://www.future-science.com/cms/10.4155/fmc.14.123/asset/images/medium/figure5.gif)
Histone methylases as novel drug targets: developing inhibitors of EZH2 | Future Medicinal Chemistry
![Cancers | Free Full-Text | Co-Treatment with the Epigenetic Drug, 3-Deazaneplanocin A (DZNep) and Cisplatin after DZNep Priming Enhances the Response to Platinum-Based Therapy in Chondrosarcomas | HTML Cancers | Free Full-Text | Co-Treatment with the Epigenetic Drug, 3-Deazaneplanocin A (DZNep) and Cisplatin after DZNep Priming Enhances the Response to Platinum-Based Therapy in Chondrosarcomas | HTML](https://www.mdpi.com/cancers/cancers-13-04648/article_deploy/html/images/cancers-13-04648-g001.png)
Cancers | Free Full-Text | Co-Treatment with the Epigenetic Drug, 3-Deazaneplanocin A (DZNep) and Cisplatin after DZNep Priming Enhances the Response to Platinum-Based Therapy in Chondrosarcomas | HTML
![3-Deazaneplanocin A (DZNep), an Inhibitor of S-Adenosylmethionine-dependent Methyltransferase, Promotes Erythroid Differentiation* - Journal of Biological Chemistry 3-Deazaneplanocin A (DZNep), an Inhibitor of S-Adenosylmethionine-dependent Methyltransferase, Promotes Erythroid Differentiation* - Journal of Biological Chemistry](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/92cbf262-0d21-488b-8f59-badc0c38a306/gr4.jpg)
3-Deazaneplanocin A (DZNep), an Inhibitor of S-Adenosylmethionine-dependent Methyltransferase, Promotes Erythroid Differentiation* - Journal of Biological Chemistry
![DZNep inhibits H3K27me3 deposition and delays retinal degeneration in the rd1 mice | Cell Death & Disease DZNep inhibits H3K27me3 deposition and delays retinal degeneration in the rd1 mice | Cell Death & Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41419-018-0349-8/MediaObjects/41419_2018_349_Fig1_HTML.jpg)
DZNep inhibits H3K27me3 deposition and delays retinal degeneration in the rd1 mice | Cell Death & Disease
![Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials | Signal Transduction and Targeted Therapy Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-019-0095-0/MediaObjects/41392_2019_95_Fig1_HTML.png)
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials | Signal Transduction and Targeted Therapy
3-Deazaneplanocin A (DZNep), an Inhibitor of the Histone Methyltransferase EZH2, Induces Apoptosis and Reduces Cell Migration in Chondrosarcoma Cells
![3-Deazaneplanocin A (DZNep), an Inhibitor of S-Adenosylmethionine-dependent Methyltransferase, Promotes Erythroid Differentiation - ScienceDirect 3-Deazaneplanocin A (DZNep), an Inhibitor of S-Adenosylmethionine-dependent Methyltransferase, Promotes Erythroid Differentiation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0021925820523168-gr1.jpg)
3-Deazaneplanocin A (DZNep), an Inhibitor of S-Adenosylmethionine-dependent Methyltransferase, Promotes Erythroid Differentiation - ScienceDirect
![The Effect of EZH2 Inhibition through DZNep on Epithelial–Mesenchymal Transition Mechanism | Cellular Reprogramming The Effect of EZH2 Inhibition through DZNep on Epithelial–Mesenchymal Transition Mechanism | Cellular Reprogramming](https://www.liebertpub.com/cms/10.1089/cell.2020.0073/asset/images/medium/cell.2020.0073_figure4b.jpg)
The Effect of EZH2 Inhibition through DZNep on Epithelial–Mesenchymal Transition Mechanism | Cellular Reprogramming
![DZNep, an inhibitor of the histone methyltransferase EZH2, suppresses hepatic fibrosis through regulating miR-199a-5p/SOCS7 pathway [PeerJ] DZNep, an inhibitor of the histone methyltransferase EZH2, suppresses hepatic fibrosis through regulating miR-199a-5p/SOCS7 pathway [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2021/11374/1/fig-5-full.png)
DZNep, an inhibitor of the histone methyltransferase EZH2, suppresses hepatic fibrosis through regulating miR-199a-5p/SOCS7 pathway [PeerJ]
![The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML - ScienceDirect The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497120407086-gr7.jpg)